BioNTech
BNTX
BNTX
287 hedge funds and large institutions have $3.78B invested in BioNTech in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 96 increasing their positions, 88 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more call options, than puts
Call options by funds: $167M | Put options by funds: $165M
0.1% less ownership
Funds ownership: 17.33% → 17.24% (-0.1%)
13% less capital invested
Capital invested by funds: $4.34B → $3.78B (-$559M)
Holders
287
Holding in Top 10
5
Calls
$167M
Puts
$165M
Top Buyers
| 1 | +$66.9M | |
| 2 | +$54.6M | |
| 3 | +$43M | |
| 4 |
BlackRock
New York
|
+$25.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.2M |
Top Sellers
| 1 | -$104M | |
| 2 | -$74.9M | |
| 3 | -$44M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$31.7M |
| 5 |
Morgan Stanley
New York
|
-$16.5M |